Health Grants in Australia (All States) — 2026

This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way. The process to get funding has 2 stages: expression of interest – outlining a proposed program of research with a 10-year time horizon full application, for a project of up to 5 years under the program of research. Full applications may be submitted by invitation only. Applicants may propose to start research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years. Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by

The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are 'de-risked' and attractive to private investment for commercialisation. Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). Eligibility: You can apply

The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. Stream 1 - Innovation enablers Address an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel platforms, and secure health data environments to create valuable research resources. Stream 2 - Digitisation of health care Translate or implement innovative artificial intelligence technologies into health applications that: benefit multiple health disciplines/areas involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and increase artificial intelligence workforce capacity and capability, particularly in relation

The National Palliative Care Projects represent a long-standing commitment by the Australian Government to improve the quality, accessibility, and coordination of palliative care services across the country. These projects have supported national leadership, innovation, and capacity-building in palliative care through investments in research, education, workforce development, and community engagement. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side. Eligibility: To be eligible you must be one of the following entity types. • Indigenous Corporation (registered under the Corporations (Aboriginal and /or Torres Strait Islander) Act 2006) • Company • Corporate Commonwealth Entity • Non-Corporate Commonwealth Statutory Authority • Corporate State or Territory Entity • Non-corporate State or Territory Entity • Non-corporate State or Territory Statutory Authority • Local Government • Cooperative • Incorporated Associati

The objective of the Synergy Grant scheme is to: • support outstanding multidisciplinary teams of investigators to work together to answer questions that cannot be answered by a single investigator. The intended outcomes of the Synergy Grant scheme are: • multidisciplinary research that addresses major problems in all areas of human health and medical research, from discovery to translation. • highly collaborative teams of diverse researchers including by gender, career stage and cultural background, working together to address major problems in human health. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available at: https://www.nhmrc.gov.au/funding/manage-your-funding/nhmrc-funding/administering-institutions Applications must satisfy all the requirements set out in the Synergy Grants 2026 Guidelines. Total Amount Available (AUD): $55,000,000.00 Estimated Grant Value (AUD): From $5

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes. The objectives of the Partnership Project scheme are to: • Meet the need for more effective integration of research evidence into health policy and service delivery • Create partnerships among policy makers, managers, service providers and researchers • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care • Be highly responsive to the priorities of government, the community and health professionals • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. Eligibility: Appications will only be accepted from NHMRC approved Administering Institut

The purpose of this grant opportunity is to allocate new commencing medical Commonwealth Supported Places (CSPs) and associated medical education and training activities which foster a positive primary care culture and influence the uptake of primary care among graduates to bolster the GP workforce, particularly in rural and underserved metropolitan areas. This grant opportunity will be implemented through two streams: Stream A and Stream B. Eligible applicants can apply for one or both streams. Streams A and B will have different application opening and closing dates. The government has announced its intention to ensure all First Nations students will receive a medical CSP when they are accepted into eligible medical schools from 2026. Implementation of this measure is subject to the passage of legislation and will be taken into account in implementation of Stream A and B of this grant opportunity. Please note: Stream A of the Grant Opportunity will close for applications at 2:00pm AE

This grant program supports researchers pursuing innovative 'moonshot' projects to develop new products and interventions for currently serious and incurable health conditions. Funding supports medical research programs with a 10-year time horizon that develop novel health technologies or repurpose existing technologies in novel ways, with the goal of achieving full clinical implementation.

This grant opportunity represents a long-standing commitment by the Australian Government to enhance palliative care services for aged care recipients by ensuring aged care providers and healthcare practitioners have access to expert advice on palliative care and advance care planning. The funding supports innovative services that strengthen collaboration between aged care, healthcare practitioners and specialist palliative care providers, improving the quality and coordination of care. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side. Eligibility: To be eligible you must be one of the following entity types: • Indigenous Corporation (registered under the Corporations (Aboriginal and /or Torres Strait Islander) Act 2006) • Company • Corporate Commonwealth Entity • Non-Corporate Commonwealth Statutory Authority • Corporate State or Territory Entity • Non-corporate State or Territory Entity • Non-corporate State or

The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer-Driven Research initiative aims to enable or support research that improves patient care and translation of new discoveries, and encourage collaboration between consumers and researchers. Funding from this Initiative will support the development of new diagnoses, treatments and cures, and the translation of new discoveries into clinical practice. Three topics of funding are available based on the primary focus of the research or the geographic location of the organisation undertaking the majority of the research. The objective of this grant opportunity is to: Topic A (Aim 2 of Research Plan; TCR): improving the mental health of First Nations children through research led by First Nations researchers that includes meaningful involvement of First Nations communities. Topic B (Aim 2 of Research Plan; TCR): the organisation undertaking the majority of the research is based in any area according to the Modified Monash

This grant supports Australian higher education providers to create additional postgraduate psychology places in courses leading to general registration and areas of practice endorsement. Round 3 provides funding in 2025-26 to build capacity within higher education institutions and grow the postgraduate qualified psychology workforce to alleviate pressure in the mental health system.

This grant opportunity provides financial support to NHMRC-accredited Research Translation Centres to accelerate research translation into healthcare and meet their strategic aims. Funding supports engagement between researchers and end-users, conducts research and translation activities aligned with health service partner priorities, and leverages additional contributions from RTC partners to improve Australian health services and systems.

This grant opportunity aims to deliver health workforce training to ensure inclusive, culturally safe healthcare for LGBTIQA+ people in Australia and establish a network of accredited primary care providers. It funds evidence-based, patient-centred training programs that reduce financial barriers for primary care providers to develop competency in LGBTIQA+-affirming care and improve health outcomes for LGBTIQA+ individuals.

This grant funds cancer research focused on early-onset cancers, aiming to enhance understanding and develop novel clinical approaches for earlier diagnosis and innovative models of care. The initiative supports programs that leverage multidisciplinary collaborative activities and link to research infrastructure initiatives to inform policy and large-scale research on early-onset cancer causes, pathogenesis, diagnosis, management and survivorship.

This grant supports medical research and medical innovation projects conducting clinical trials for rare cancers, rare diseases, and unmet health needs. It aims to improve the evidence base supporting clinical care, help patients access relevant trials, and enable researchers to bring international trials to Australian patients. The initiative funds four streams: pilot feasibility studies, clinical trials for rare conditions, trials supporting health technology assessment, and prevention clinical trials.

Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer questions that cannot be answered by a single investigator. These grants fund multidisciplinary research that addresses major problems in all areas of human health and medical research, from discovery to translation, with highly collaborative teams of diverse researchers working together.

This NHMRC grant opportunity funds implementation research addressing strategies for strengthening health systems to improve equity in high quality care and health outcomes, and reduce the prevalence and impact of non-communicable diseases. Research must focus on low- and middle-income countries (LMICs) and/or underserved populations experiencing health disparities, with additional priority for Australian Aboriginal and Torres Strait Islander communities and Southeast Asia and Pacific region collaborations.

This grant opportunity seeks to investigate short and long-term adverse health outcomes experienced by individuals living in unstable housing conditions. Research will inform the development of comprehensive interventions to improve health outcomes and reduce health disparities among people experiencing homelessness in Australia. Initiatives should foster collaboration among health service providers, academic institutions, researchers and communities with a holistic approach to health.

The NHMRC e-ASIA Joint Research Program supports Australian participation and collaboration in leading international research through the e-ASIA Joint Research Program (e-ASIA JRP). The e-ASIA JRP supports international joint research projects in the East Asia region. The e-ASIA JRP selects research projects through an open call for proposals. Fields of cooperation are decided among the e-ASIA participating member organisations and funding is for up to three years. The 2026 NHMRC e-ASIA Joint Research Program grant opportunity will support Australian participation and partnership in international collaborative research through the e-ASIA JRP 15th call for proposals in Health Research stream under the following topics: • Infectious disease and immunology • Advanced medical research and enabling technologies Further information on the e-ASIA JRP 15th Health Research call is available from the e-ASIA website Eligibility: Applications will only be accepted from NHMRC approved Administering

Supports Australian participation and collaboration in leading international collaborative research through the e-ASIA Joint Research Program on a multilateral basis. Funding supports up to 6 grants for the Australian component of successful projects in the e-ASIA JRP 15th Health Research stream, addressing research topics in Infectious Diseases and Immunology or Advanced Medical Research & Enabling Technologies.

The 2026 NHMRC-European Partnership for Brain Health (EP BrainHealth) Grant Opportunity supports Australian participation and collaboration in transnational research projects through European Partnership for Brain Health (EP BrainHealth) Call for Proposals. The EP BrainHealth offers 2 calls: one in the field of neurological, mental disorders and sensory disorders (EP BrainHealth Call 1) and one in the field of neurodegenerative disorders (EP BrainHealth Call 2). Further information on the EP BrainHealth Call for Proposals is available from the EP BrainHealth website. Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. • Australia-based researchers must submit an application at the full proposal stage to both NHMRC and the EP BrainHealth Secretariat to be considered for 2026 NHMRC-EP BrainHealth funding. A copy of the full proposal as submitted to EP BrainHealth must be included in the 2026 NHMRC-EP BrainHealth application for funding. • The C

The 2025 NHMRC-Horizon Europe grant opportunity supports Australian participation in international collaborative research under Horizon Europe. Horizon Europe facilitates collaboration and strengthens research impact and innovation while tackling global challenges. NHMRC will invite Australia-based researchers who are listed on eligible applications deemed fundable by the European Commission (EC) to apply to NHMRC for support of the Australian component of research under the following topics submitted under the Horizon Europe topics listed in section 2.4 of the 2025 NHMRC-Horizon Europe Guidelines. Applicants should note that the topics are listed either under a single stage deadline model or a two-stage deadline model and have different submission dates: Single stage deadline model – 29 April 2026 Two-stage deadline model – 25 November 2026 Eligibility: Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institution

NHMRC is providing up to $4 million to support Australia-based researchers participating as partners in transnational consortia through the European Partnership for Brain Health. The funding supports research projects on biological, social and environmental factors that impact the trajectory of brain health across the lifespan, with two calls covering neurological/mental/sensory disorders and neurodegenerative disorders.

Supports Australian participation in leading international collaborative research under Horizon Europe, the European Union's key funding program for research and innovation. NHMRC selects topics that align with health priorities and supports collaborative approaches to health and medical research internationally across multiple research areas including disease prevention, advanced therapies, and medical device innovation.

A one-off grant opportunity running over three years (FY2025-26 through FY2027-28) that directs additional investment to Australia's Multi-site Collaborative Cancer Clinical Trials Groups under the Support for Cancer Clinical Trials program. The fund aims to build capacity and develop methods to accelerate the incorporation of genomics into the design of cancer clinical trial concepts and protocols to benefit all CTGs.

This grant supports medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials. It aims to increase clinical trial activity in Australia by establishing and coordinating clinical trial sites, providing high-quality evidence of novel health treatments, drugs, or devices in usual care settings.

Supports Australian participation and collaboration in leading international collaborative research through the e-ASIA Joint Research Program on a multilateral basis. The program funds up to 4 grants for the Australian component of successful projects addressing Infectious Diseases and Immunology (including Antimicrobial Resistance) in the Health Research stream, with funding for up to 3 years.

The CRE scheme provides support for teams of researchers to pursue collaborative research and develop capacity in basic science research, clinical research, health services research, and public health research. The scheme aims to improve health outcomes and promote translation of research outcomes into policy and/or practice, while supporting capacity building activities in the health and medical research workforce.

This grant funds the delivery of the Bidyadanga Healing Model, which integrates First Nations healing methodologies with therapeutic practices to strengthen identity, safety and resilience in the community. Successful applicants must demonstrate cultural competence, genuine community relationships, and capability to deliver culturally-led healing services with long-term commitment and participatory engagement.

This grant supports medical research and medical innovation projects aimed at improving outcomes for Australians with traumatic brain injury (TBI). It offers two streams: Stream 1 focuses on testing novel treatments and interventions for moderate to severe TBI, while Stream 2 supports research on implementing clinical guidelines for mild TBI with attention to equity and access across diverse populations.

This funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. Partnership Projects answer a specific research question to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret findings and implement them into policy and practice. Partnership Projects answer specific research questions to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.

This funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. Partnership Projects answer a specific research question to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

This funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice. Partnership Projects answer a specific research question to influence health and well-being through changes in the delivery, organisation, funding and access to health services.

This program funds innovative projects that champion opportunities for women and girls in NSW, focusing on three pillars: economic opportunity and advancement, health and wellbeing, and participation and empowerment. Funding supports majority women-owned and managed small businesses, social enterprises, and not-for-profits to deliver projects aligned with the NSW Women's Strategy (2023-2026).

This program provides funding for industry groups, organisations and private businesses to deliver community events and programs that promote good mental health in agriculture, particularly during stressful and challenging times like drought. Events and initiatives are tailored to unique community needs.

A program inviting First Nations people, organisations and communities to co-design, trial and evaluate projects aimed at contributing to Closing the Gap Targets 12 (out-of-home care) and 13 (family violence). The Fund supports trial projects with evaluation to improve the evidence base for the Australian Government and First Nations people, with projects running until 30 June 2026.

This fund supports First Nations people, organisations and communities to co-design, trial and evaluate projects aimed at contributing to Closing the Gap Targets 12 (reducing over-representation of Aboriginal and Torres Strait Islander children in out-of-home care) and 13 (reducing family violence and abuse against Aboriginal and Torres Strait Islander women and children). All trial projects will be subject to evaluation to collect evidence and assess outcomes.

This program provides NSW small to medium enterprises with support measures to help them attain new business in targeted global markets. Participants receive expert-led workshops, market intelligence briefings, cultural and pitch training, introductions to potential partners and buyers, and in-market visits with specialist staff support.

The MDPP supports inventors from research, industry and clinical settings to develop new medical devices and assistive technologies through early-stage development. Participants receive up to 250 hours of technical expertise including research, proof of concept, prototyping, product validation, and introductions to potential manufacturers and commercial partners.

A free and confidential mental health coaching program designed to support small business owners and sole traders. Participants receive 6 free mental health coaching sessions plus 2 follow-up sessions with no GP referral required.

The Workforce Incentive Program provides general practices with funding to build a sustainable and high quality health workforce, particularly in rural and remote areas. It supports practices to engage eligible health professionals in promoting preventative health, chronic disease management, and care coordination. Payments include quarterly incentive payments, rural loading of up to 50%, and annual loading for practices serving Veterans' Affairs Gold Card holders.

The MRFF Clinical Trials Activity Initiative provides grants to support medical research projects conducting clinical trials for rare cancers, rare diseases, and unmet health needs across four streams: feasibility pilots, targeted clinical trials, health technology assessment evidence trials, and prevention trials. The grant aims to improve evidence-based healthcare delivery and increase patient access to high-quality clinical trials in Australia.

The ITRP supports university researchers to partner with industry in priority areas for Australia. It includes Industrial Transformation Research Hubs that fund research projects focused on issues facing industry, and Industrial Transformation Training Centres that support Higher Degree by Research (HDR) students and postdoctoral researchers to gain practical skills and experience through industry placements.

This program provides up to 1,000 eligible small business owners with 3 one-hour mentoring sessions to be used within 3 months. Experienced mentors offer advice on business topics including marketing, communication, finance, strategic planning, digitalisation, and change management. The program supports small businesses in 6 priority sectors: advanced manufacturing and defence, agribusiness, circular economy, digital technologies, health technologies and medical research, and regional tourism.

This grant supports medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials through establishment and coordination of clinical trial sites in Australia. It funds research providing high-quality evidence of the effectiveness of novel health treatments, drugs or devices in usual care settings to support decisions on delivering interventions in Australian settings.

This MRFF grant supports large-scale implementation research projects that bring evidence-based preventions and treatments for children's mental health into practice through partnerships with local health and community service providers. Projects must be co-produced with children, families, carers, and communities, support integration of mental health services, build clinical research workforce capacity, and measure intervention impact. Three funding topics are available targeting First Nations-led research, organizations across all Modified Monash Model areas, or those in regional, rural, and remote areas.

This grant opportunity supports medical research and medical innovation projects focused on traumatic brain injury. Stream 1 funds research testing novel treatments and interventions for moderate to severe traumatic brain injury to reduce acute care time and improve long-term outcomes. Stream 2 supports research on effective national adoption and best practice use of clinical guidelines for mild traumatic brain injury, including addressing implementation barriers and inequalities across diverse populations.

The Ideas Grant scheme supports innovative research projects addressing specific questions in health and medical research. It funds researchers at all career stages across any area of health and medical research from discovery to implementation, with funding duration of 1 to 5 years.

This grant supports medical research and medical innovation projects conducting clinical trials across four streams: pilot studies for new clinical trials in rare cancers/diseases, clinical trials for rare cancers and unmet needs, clinical trials supporting high-value care and health technology assessment, and prevention clinical trials. The intended outcome is to improve health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.

Investigator Grants provide consolidated funding for salary and research support to high-performing researchers at all career stages. The grants support research across biomedical, clinical, public health, and health services research pillars, allowing researchers flexibility to pursue new research directions and form collaborations.

This grant supports medical research and medical innovation projects that develop novel approaches to reduce treatment toxicity and adverse effects of brain cancer treatment. The objective is to improve the health and wellbeing of Australians by reducing the burden caused by brain cancer treatments and improving quality of life for people affected by brain cancer, including their carers.

This grant supports medical research and medical innovation projects focused on cardiovascular disease and stroke prevention, clinical trials for novel devices and therapeutic approaches, and recovery trajectories in cardiovascular disease and stroke. Four streams are available: Stream 1 targets Aboriginal and Torres Strait Islander cardiovascular prevention strategies; Stream 2 supports Phase 1 and Phase 2 clinical trials; Stream 3 focuses on multiomics projects for recovery understanding; and Stream 4 addresses prevention through novel therapeutics, risk prediction markers, and tailored preventive care approaches.

This grant supports medical research and innovation projects investigating post-acute sequelae of COVID-19 (PASC) through two streams: Stream 1 focuses on small-scale developmental projects examining molecular mechanisms, pathways, biomarkers, and prognostic factors of PASC; Stream 2 evaluates multidisciplinary, consumer-centred models of care for people with PASC, with specific topics addressing regional, rural, First Nations, disability, culturally and linguistically diverse, and frail older populations.

This grant opportunity supports medical research and medical innovation projects focused on implementation research to improve quality of life for Australians as they age. Stream 1 funds research addressing inequalities in uptake of prevention activities for Aboriginal and Torres Strait Islander peoples, rural/regional/remote populations, and culturally and linguistically diverse populations. Stream 2 funds research to understand barriers and enablers to adoption of high-quality care for older Australians across different care settings and population groups.

This Medical Research Future Fund (MRFF) grant supports medical research and medical innovation projects across three streams: early-stage research led by early career researchers (Incubator), large-scale interdisciplinary programs led by mid-career researchers (Accelerator), and co-funded translation research (Targeted Call). The grants aim to improve health and wellbeing of Australians by supporting innovative solutions and translating research into practice for Priority Populations.

This grant supports medical research and medical innovation projects in two streams: Stream 1 focuses on developing and implementing pharmacogenomic approaches to identify new medicines and enhance medication efficacy across cancer therapies, antimicrobials, and other infectious or chronic diseases; Stream 2 conducts genomics research to optimise diagnosis, treatment, monitoring and prevention of high-priority diseases among Aboriginal and/or Torres Strait Islander peoples.

This grant supports medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials through establishment and coordination of clinical trial sites in Australia. It funds research providing high-quality evidence of the effectiveness of novel health treatments, drugs or devices in 'usual care' settings to support decisions on delivering interventions in Australian settings.

This Medical Research Future Fund (MRFF) grant supports medical research and innovation projects that develop consumer-informed approaches to incorporating patient data in health technology assessment across medicines, vaccines, and medical devices, as well as approaches to evaluating long-term effectiveness and safety of specialized therapies and implantable devices. The grant aims to improve health technology assessment decision-making and long-term health outcomes for Australians through better integration of patient perspectives and reported outcomes.

This grant provides financial assistance to support medical research and medical innovation projects that develop scalable and sustainable interventions to mitigate the impact of climate change on Australians' mental health. Projects must be co-designed with consumers and health services. The anticipated outcome is to improve the health and wellbeing of Australians by addressing the mental health impacts of climate change.

This Medical Research Future Fund (MRFF) grant supports research into new ways to address preventive and public health issues in Australia, including risk factors and early detection, diagnosis and treatment of chronic and complex diseases. The grant has three streams: improving prevention and management of perinatal mental ill-health, improving healthy development in early childhood, and promoting healthy lifestyle and preventive health approaches in adolescents, young adults and middle-aged people.

This grant supports medical research and innovation projects developing and delivering innovative, safe and effective stem cell medicines to improve health outcomes. It funds two streams: early stage clinical trials (Phase I/IIa) of new stem cell therapies, and research on ethical frameworks, regulatory approaches, community understanding, and health economics of stem cell therapies.

The NHMRC Postgraduate Scholarships scheme funds successful applicants to attain a research-based postgraduate degree (Doctor of Philosophy or Research Masters Degree). It supports outstanding health and medical graduates early in their career to conduct internationally competitive research and develop capacity for original independent research within Australia.

An equity co-investment venture capital program that provides early-stage biomedical companies with investment to develop and commercialise biomedical discoveries. The fund supports therapeutic, medical, pharmaceutical products, processes, services, technologies and procedures that improve health and wellbeing through prevention, diagnosis and treatment.

The Biomedical Translation Fund provides capital to support groundbreaking innovation in Australia, helping commercialize research from universities and research organizations into commercial products. The fund pools $500 million in total capital ($250 million from the federal government and $250 million from private investors) to support venture capital managers in taking Australian biomedical innovations through the commercial pathway.

A legislated tax offset program that supports companies to invest in eligible research and development by offsetting some of the associated costs. The program provides refundable or non-refundable tax offsets based on company turnover and R&D expenditure proportions, with offsets up to $150 million.

The CRC Grants Program provides funding to establish and operate Cooperative Research Centres that bring together researchers, industry, and other partners to conduct collaborative research. The program supports multiple active CRCs across various sectors including digital health, agriculture, manufacturing, energy, and environmental sustainability, with funding terms typically spanning 10 years.

This grant provides emergency funding to IAHP funded organisations in response to urgent or unforeseen issues that may arise. Approved activities include purchasing necessary equipment to ensure continuity of service delivery, targeted funding to respond to emergency health needs, and purchasing, repairing or installing equipment or infrastructure due to natural disaster or incident.

This grant program is delivered, in part, through the collection of data, ongoing surveillance, and pertinent research and evaluation activities related to the BBV and STI outlined in the National BBV and STI Strategies, namely: National Hepatitis B Strategy National Hepatitis C Strategy National STI Strategy National Aboriginal and Torres Strait Islander BBV and STI Strategy National HIV Strategy. The Department’s First National BBV and STI Research Strategy 2021-2025 and its future iterations (the National BBV and STI Research Strategy), sets out the aims and objectives for the multi-disciplinary research activities undertaken within Australia and supports the implementation of the related National BBV and STI Strategies. By enabling and focussing on the conduct of BBV and STI research, the Research Strategy aims to identify challenges, barriers and opportunities to achieve the agreed national goals and targets of the National BBV and STI Strategies. The Research Strategy also contai

The Development Grant scheme supports proof-of-concept research with a feasible commercialisation pathway and high likelihood of producing protected intellectual property. It aims to expedite the translation of health and medical research outcomes through to commercialisation within a foreseeable timeframe. The scheme intends to increase rates of translation of health and medical research into commercial outcomes, resulting in improved health and medical knowledge.

SMEC AI accelerates SME adoption of artificial intelligence in priority industries including enabling capabilities, medical science, agriculture, and renewables. The program operates through two key activities: an SME AI Adoption Centre providing consultations and training, and an SME AI Studio creating and supporting new AI products in collaboration with SMEs to solve industry problems.

This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.

A Commonwealth grant program that provides funding to support the establishment and operation of business incubators and accelerators across Australia. The program funds various types of incubation programs including regional incubators, sector-specific accelerators, and programs targeting specific entrepreneur demographics.

The National Reconstruction Fund Corporation (NRFC) provides debt finance, equity finance and guarantees for businesses with compelling proposals in priority areas of the Australian economy. Applicants can seek funding for proposals in renewables and low emissions technologies, medical science, transport, value-add in agriculture/forestry/fisheries, value-add in resources, defence capabilities, and enabling capabilities.

The Practice Incentives Program provides funding for general practices to help them continuously improve, provide quality care, enhance capacity and improve access and health outcomes for patients. Payments are available for various activities including eHealth, quality improvement, teaching, aged care access, Indigenous health, after hours care, procedural activities, and rural locations.

Long-term, industry-led research collaboration funding that supports cooperative research efforts between industry, government, and research institutions. The program provides a platform for innovative projects requiring expertise from multiple sectors to deliver tangible outcomes.

The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.

A venture capital program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

The Industry Growth Program provides access to specialists, networks, and grants to help early-stage startups develop and grow their companies locally and globally. The program offers advisory services and expert guidance to support the successful building of innovative businesses.

The WIP – Doctor Stream provides direct financial payments to medical practitioners who deliver eligible primary care services in rural and remote areas of Australia. Payments are made through two systems: the Central Payment System (CPS) for doctors billing the Medicare Benefits Schedule, and the Flexible Payment System (FPS) for doctors providing eligible services or undertaking training not reflected in the MBS. Payment amounts vary based on activity levels, duration in the program, and vocational registration status.

The Biomedical Translation Fund supports the development and commercialization of biomedical innovations, including medical devices, treatments, and therapies. It provides capital and business support to help move research from the laboratory to clinical trials and patient applications.

The CRC Program supports industry-led collaborations between industry, researchers and the community to focus on research and development towards use and commercialisation. The program funds long-term, collaborative research initiatives that link researchers with industry partners.

A tax incentive program that deems clinical trial activities as core R&D activities eligible for the R&D Tax Incentive. Companies conducting clinical trials registered with the TGA can claim tax benefits for their R&D activities related to these trials.

A tax offset program that provides financial support to eligible corporations conducting research and development activities in Australia. Companies can claim tax offsets based on eligible R&D expenditure, with enhanced benefits for smaller companies and those using registered research service providers.

The VCLP program provides attractive tax benefits for venture capital investors to make early or late stage investments in innovative Australian businesses. It supports the commercialisation of promising technologies developed by Australian research institutions and startups.

The ARC Centres of Excellence Program supports high-quality groups of researchers working in areas of national and international importance for Australia. Centres partner with strategic industry and research organisations to undertake innovative and potentially transformational research, develop international networks, and build Australia's research capacity. The program establishes focal points of expertise that maintain and develop Australia's international standing in research areas of national priority.

A grant program that funds collaborative research projects between industry, research organizations, and universities. This example supported the development of AI-based telehealth technology for knee replacement rehabilitation monitoring, with the grant providing $1.2 million toward the project.

A tax offset program that allows eligible companies to claim tax deductions for research and development activities conducted overseas. Companies must obtain an Overseas Finding before registering and claiming a tax offset for overseas R&D activities, demonstrating that the work cannot be conducted in Australia and meets specific scientific and cost conditions.

A tax incentive program that supports companies conducting research and development activities in Australia. The RDTI enables companies to take risks and perform experiments where outcomes are uncertain, helping to build research infrastructure and attract investment in sectors like biotechnology.

A venture capital program that provides funding to support innovative Australian businesses and technology companies. The program facilitates investment through limited partnerships to help build Australia's next generation of technology leaders and support ventures in sectors like aviation decarbonization and pharmaceuticals.

This grant supports new, adaptive platform trials (Phase 2 or 3) in areas of unmet clinical need through international collaboration between Australia and the UK. The funding aims to invest in ambitious platform trials that support increased access to high-quality, evidence-based and effective health care. MRFF and NHMRC funding is available to support the Australian-based arm of the proposed trial.

This funding scheme supports high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. The grants fund research proposals for clinical trials and/or cohort studies of any size, aiming to produce reliable evidence of health-related interventions and the relationship between risk factors and health outcomes.

The purpose of the Indigenous Employment Initiative (IEI) is to create entry level employment opportunities for Aboriginal and Torres Strait Islander people who will support the provision of culturally safe, trauma aware, and healing informed aged care to older Aboriginal and Torres Strait Islander people through a suitably skilled workforce. The objectives are to: • ensure that Aboriginal and Torres Strait Islander people are provided employment and training opportunities in their communities in entry level, non-clinical aged care positions • provide culturally safe training programs to develop an Aboriginal and Torres Strait Islander workforce that will provide high quality services and meet community needs • provide culturally safe, trauma aware, and healing informed aged care to older Aboriginal and Torres Strait Islander people on country and/or close to home • improve the quality and access to aged care services for Aboriginal and Torres Strait Islander people • support the expan

This grant supports Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types to develop and implement new approaches for addressing unmet medical needs. Funding covers projects that create new linkages of data from at least two different existing research data infrastructure sources or apply novel methodologies that leverage and enhance existing linked research data infrastructure.